G-H-3 International Inc. (GHTI) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Pharmaceuticals Branche. Der Hauptsitz des Unternehmens ist in Las Vegas, United States. Der aktuelle CEO ist Flo Ternes.
GHTI hat IPO-Datum 2023-06-05, gelistet an der Other OTC.
G-H-3 International Inc. develops products for addressing factors, which cause aging and deterioration in the body. Its product, G-H-3-Plus is a comprehensive protocol that promotes anti-aging, treat chronic disease, and improve health and vitality. The G-H-3-Plus protocol includes a combination of intravenous treatment, intramuscular injections, prescriptions, vitamins, and skin care products. The company was formerly known as The Chelsea Collection, Inc. and changed its name to G-H-3 International Inc. G-H-3 International, Inc. is based in Las Vegas, Nevada.
